-
公开(公告)号:US20200010913A1
公开(公告)日:2020-01-09
申请号:US16576643
申请日:2019-09-19
Applicant: MYRIAD GENETICS, INC.
Inventor: Victor Abkevich , Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/6886
Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号:US10519513B2
公开(公告)日:2019-12-31
申请号:US16256908
申请日:2019-01-24
Applicant: Myriad Genetics, Inc.
Inventor: Steven Stone , Alexander Gutin , Susanne Wagner , Julia Reid
IPC: C12Q1/6886 , G16B20/00 , G16B40/00
Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
-
公开(公告)号:US09976188B2
公开(公告)日:2018-05-22
申请号:US15588458
申请日:2017-05-05
Applicant: Myriad Genetics, Inc.
Inventor: Steven Stone , Alexander Gutin , Susanne Wagner , Julia Reid
CPC classification number: C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/158 , G06F19/18 , G06F19/24
Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
-
公开(公告)号:US20170283879A1
公开(公告)日:2017-10-05
申请号:US15433249
申请日:2017-02-15
Applicant: Myriad Genetics, Inc.
Inventor: Victor Abkevich , Kirsten Timms , Alexander Gutin , Julia Reid
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/106 , C12Q2600/156
Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of homologous recombination deficiency (HRD) or an HRD signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an HRD signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号:US20170130263A1
公开(公告)日:2017-05-11
申请号:US15412404
申请日:2017-01-23
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
CPC classification number: C12Q1/6827 , C12Q1/6858 , C12Q1/6874 , C12Q1/6883 , G16B30/00 , C12Q2535/122 , C12Q2537/143
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
-
公开(公告)号:US20150167103A1
公开(公告)日:2015-06-18
申请号:US14632888
申请日:2015-02-26
Applicant: Myriad Genetics, Inc.
Inventor: Steven Stone , Alexander Gutin , Susanne Wagner , Julia E. Reid
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158
Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
Abstract translation: 提供了使用生物标志物预测患者癌症复发风险的生物标志物和方法。
-
公开(公告)号:US20140278135A1
公开(公告)日:2014-09-18
申请号:US14209703
申请日:2014-03-13
Applicant: Myriad Genetics, Inc.
Inventor: Dmitry Pruss , Brian Morris , Karla Bowles , Julie M. Eggington , Benjamin B. Roa , Alexander Gutin , Elisha Hughes
Abstract: A computer-implemented method is discussed that includes identifying, by a computer server system, stored electronic data that represents genetic sequencing for one or more genes for individuals in a population of patients who have submitted to genetic sequencing; generating, for each of multiple individuals and from the stored electronic data, probability data for the individuals and probability or weighting data, or both, for relatives of the individuals, the probability data representing likelihoods that a particular person corresponding to the probability data carries a deleterious mutation in a particular gene; and generating a score for a genetic variant, wherein the score is a function of probability or weighting data, or both, for the individuals and for relatives of the individuals, and the score represent a composite probability that a certain variant is a deleterious or benign variant.
Abstract translation: 讨论了一种计算机实现的方法,其包括由计算机服务器系统识别代表已经进行遗传测序的患者群体中的个体的一个或多个基因的遗传测序的存储的电子数据; 为个人的个人和存储的电子数据生成个人的概率数据和个人的亲属的概率或加权数据或两者,表示对应于概率数据的特定人物的可能性携带的概率数据 特定基因中的有害突变; 以及为遗传变异产生得分,其中所述得分是所述个体和所述个体的亲属的概率或加权数据或两者的函数,并且所述分数表示某个变体是有害或良性的复合概率 变体。
-
公开(公告)号:US20140134166A1
公开(公告)日:2014-05-15
申请号:US14161453
申请日:2014-01-22
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Srikanth Jammulapati , Susanne Wagner
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C07K14/47 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158
Abstract: Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular detection and classification of disease are provided.
-
-
-
-
-
-
-